Download Files:
IV-361
$1,050 – $8,400
Products Details
Product Description
– IV-361 is an orally active and selective CDK7 inhibitor (Ki≤50 nM). IV-361 has anti-cancer activity (US20190256531A1)[1].
Web ID
– HY-139011
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C23H32FN5O2Si
References
– [1]Noriaki Iwase, et al. Substituted dihydropyrrolopyrazole derivative. US20190256531A1.
CAS Number
– 2055741-39-2
Molecular Weight
– 457.62
Compound Purity
– 98.64
SMILES
– O=C(N(C1)C(C)(C)C2=C1C(NC(C3([Si](C)(C)C)CCC3)=O)=NN2)NC4=CC(F)=CC=C4C
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– DMSO : 90 mg/mL (ultrasonic)
Target
– CDK
Isoform
– CDK2;CDK7
Pathway
– Cell Cycle/DNA Damage
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
